Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nancy E Davidson

Showing results (161-170 of 285) with videos related to

Pageof 29
Sort By:
Oncotarget|November 16, 2017
Functional characterization of lysine-specific demethylase 2 (LSD2/KDM1B) in breast cancer progressionLin Chen, Shauna N Vasilatos, Ye Qin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 3, 2006
Quantitative multiplex methylation-specific PCR analysis doubles detection of tumor cells in breast ductal fluidMary Jo Fackler, Kara Malone, Zhe Zhang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 15, 2009
Local excision alone without irradiation for ductal carcinoma in situ of the breast: a trial of the Eastern Cooperative Oncology GroupLorie L Hughes, Molin Wang, David L Page, et al.
Oncogene|August 17, 2018
Inhibition of histone lysine-specific demethylase 1 elicits breast tumor immunity and enhances antitumor efficacy of immune checkpoint blockadeYe Qin, Shauna N Vasilatos, Lin Chen, et al.
The Journal of Biological Chemistry|May 9, 2006
Polyamine analogues down-regulate estrogen receptor alpha expression in human breast cancer cellsYi Huang, Judith C Keen, Allison Pledgie, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 17, 2015
Long-Term Follow-Up of the E1199 Phase III Trial Evaluating the Role of Taxane and Schedule in Operable Breast CancerJoseph A Sparano, Fengmin Zhao, Silvana Martino, et al.
Breast Cancer Research : BCR|February 18, 2025
Fluoroestradiol (FES) and Fluorodeoxyglucose (FDG) PET imaging in patients with ER+, HER2-positive or HER2-negative metastatic breast cancerNatasha B Hunter, Lanell M Peterson, Jennifer M Specht, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 2006
HER2 testing by local, central, and reference laboratories in specimens from the North Central Cancer Treatment Group N9831 intergroup adjuvant trialEdith A Perez, Vera J Suman, Nancy E Davidson, et al.
Scientific Reports|November 25, 2018
Whole genome amplification of cell-free DNA enables detection of circulating tumor DNA mutations from fingerstick capillary bloodRekha Gyanchandani, Erik Kvam, Ryan Heller, et al.
Journal of the National Cancer Institute|June 6, 2002
Concordance between local and central laboratory HER2 testing in the breast intergroup trial N9831Patrick C Roche, Vera J Suman, Robert B Jenkins, et al.
Pageof 29

Showing results (161-170 of 285) with videos related to

Sort By:
Pageof 29
Oncotarget|November 16, 2017
Functional characterization of lysine-specific demethylase 2 (LSD2/KDM1B) in breast cancer progressionLin Chen, Shauna N Vasilatos, Ye Qin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 3, 2006
Quantitative multiplex methylation-specific PCR analysis doubles detection of tumor cells in breast ductal fluidMary Jo Fackler, Kara Malone, Zhe Zhang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 15, 2009
Local excision alone without irradiation for ductal carcinoma in situ of the breast: a trial of the Eastern Cooperative Oncology GroupLorie L Hughes, Molin Wang, David L Page, et al.
Oncogene|August 17, 2018
Inhibition of histone lysine-specific demethylase 1 elicits breast tumor immunity and enhances antitumor efficacy of immune checkpoint blockadeYe Qin, Shauna N Vasilatos, Lin Chen, et al.
The Journal of Biological Chemistry|May 9, 2006
Polyamine analogues down-regulate estrogen receptor alpha expression in human breast cancer cellsYi Huang, Judith C Keen, Allison Pledgie, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 17, 2015
Long-Term Follow-Up of the E1199 Phase III Trial Evaluating the Role of Taxane and Schedule in Operable Breast CancerJoseph A Sparano, Fengmin Zhao, Silvana Martino, et al.
Breast Cancer Research : BCR|February 18, 2025
Fluoroestradiol (FES) and Fluorodeoxyglucose (FDG) PET imaging in patients with ER+, HER2-positive or HER2-negative metastatic breast cancerNatasha B Hunter, Lanell M Peterson, Jennifer M Specht, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 2006
HER2 testing by local, central, and reference laboratories in specimens from the North Central Cancer Treatment Group N9831 intergroup adjuvant trialEdith A Perez, Vera J Suman, Nancy E Davidson, et al.
Scientific Reports|November 25, 2018
Whole genome amplification of cell-free DNA enables detection of circulating tumor DNA mutations from fingerstick capillary bloodRekha Gyanchandani, Erik Kvam, Ryan Heller, et al.
Journal of the National Cancer Institute|June 6, 2002
Concordance between local and central laboratory HER2 testing in the breast intergroup trial N9831Patrick C Roche, Vera J Suman, Robert B Jenkins, et al.
Pageof 29